Category:Hongyan ZHANG

Hongyan ZHANG

Executive Summary

Hongyan ZHANG is an inventor who has filed 4 patents. Their primary areas of innovation include MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media (4 patents), Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants (3 patents), SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS (2 patents), and they have worked with companies such as SUZHOU RIBO LIFE SCIENCE CO., LTD. (4 patents). Their most frequent collaborators include (4 collaborations), (2 collaborations), (2 collaborations).

Patent Filing Activity

Technology Areas

List of Technology Areas

• C12N2310/14 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 4 patents
• C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 3 patents
• A61P3/06 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 2 patents
• C12N2310/321 (2'-O-R Modification): 2 patents
• C12N2310/351 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
• A61K47/549 ({Sugars, nucleosides, nucleotides or nucleic acids}): 2 patents
• C12N2310/322 (2'-R Modification): 2 patents
• A61K47/54 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 2 patents
• A61P31/20 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• C12N15/1131 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 1 patents
• A61P31/04 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• C12N2310/315 (of the backbone): 1 patents
• C12N15/1137 ({against enzymes (viral enzymes): 1 patents
• A61K47/543 ({Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine}): 1 patents
• A61K47/545 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61P19/06 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• C12N2310/31 (of the backbone): 1 patents
• A61K31/713 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents

Companies

List of Companies

• SUZHOU RIBO LIFE SCIENCE CO., LTD.: 4 patents

Collaborators

• Shan GAO (4 collaborations)
• Zicai LIANG (2 collaborations)
• Haitao LI (2 collaborations)
• Daiwu KANG (2 collaborations)